Nastech Pharmaceutical (Nasdaq: NSTK) Director, Gerald Stanwick, bought 10,000 shares on 5/12 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE